Skip to main content
. 2014 Dec 24;18(5):604–612. doi: 10.1007/s11102-014-0618-1

Fig. 4.

Fig. 4

Mean (±SE) a HbA1c and b fasting plasma glucose over time from baseline up to 24-month data cut-off in the 162 patients who received at least one dose of pasireotide